VJHemOnc is committed to improving our service to you

IMW 2019 | Risk-adapted therapy in smoldering myeloma

VJHemOnc is committed to improving our service to you

Maria-Victoria Mateos

In this video, Maria-Victoria Mateos, MD, PhD, from the University of Salamanca, Salamanca, Spain, expresses the importance of risk-adapted therapy in myeloma. This interview was recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter